Priti Mehta

ORCID: 0000-0002-6153-2145 · 1 paper in corpus
review 2024
Pharmaceuticals (Basel, Switzerland) ·doi:10.3390/ph18010036

Overexpression of the gonadotropin-releasing hormone receptor (GnRH-R) plays a vital role in the advancement of reproductive malignancies such as ovarian, endometrial, and prostate cancer. Peptidomimetic GnRH antagonists are a substantial t…